Fibrinogen's potential role in connecting cerebrovascular abnormalities with glymphatic dysfunction in Alzheimer's disease

被引：0
|
作者：
Vishal Singh [1 ]
Arnab Choudhury [1 ]
Hyung Jin Ahn [1 ,2 ]
机构：
[1] Department of Pharmacology,Physiology and Neurosciences,Rutgers-New Jersey Medical School
[2] Brain Health Institute,Rutgers University
来源：
Neural Regeneration Research | 2025年 / 01期
关键词：
D O I：
暂无
中图分类号：
R749.16 [];
学科分类号：
100203 ;
摘要：
Alzheimer’s disease(AD) stands out as the primary manifestation of age-related dementia, portraying a chronic neurodegenerative disorder distinguished by the accumulation of fibrillar amyloid-β(Aβ) plaques and neurofibrillary tangles of hyperphosphorylated tau. However, from a clinical standpoint, AD presents itself as a complex condition with a spectrum of dysfunctions rather than a singular pathological mechanism.
引用
收藏
页码：203 / 204
页数：2
相关论文
共 50 条
  • [41] Alzheimer's Disease: Cerebrovascular Dysfunction, Oxidative stress, and Advanced Clinical Therapies
    Marlatt, Michael W.
    Lucassen, Paul J.
    Perry, George
    Smith, Mark A.
    Zhu, Xiongwei
    JOURNAL OF ALZHEIMERS DISEASE, 2008, 15 (02) : 199 - 210
  • [42] The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimer's disease
    Aliev, G
    Smith, MA
    Seyidova, D
    Neal, ML
    Lamb, BT
    Nunomura, A
    Gasimov, EK
    Vinters, HV
    Perry, G
    LaManna, JC
    Friedland, RP
    BRAIN PATHOLOGY, 2002, 12 (01) : 21 - 35
  • [43] II. Cerebrovascular dysfunction in Alzheimer's dementia
    Reilly, CE
    JOURNAL OF NEUROLOGY, 1999, 246 (03) : 227 - 228
  • [44] Gender differences in white matter pathology and mitochondrial dysfunction in Alzheimer’s disease with cerebrovascular disease
    Xavier Gallart-Palau
    Benjamin S. T. Lee
    Sunil S. Adav
    Jingru Qian
    Aida Serra
    Jung Eun Park
    Mitchell K. P. Lai
    Christopher P. Chen
    Raj N. Kalaria
    Siu Kwan Sze
    Molecular Brain, 9
  • [45] Mitochondrial Aβ:: A potential cause of metabolic dysfunction in Alzheimer's disease
    Chen, Xi
    Yan, Shi Du
    IUBMB LIFE, 2006, 58 (12) : 686 - 694
  • [46] Gender differences in white matter pathology and mitochondrial dysfunction in Alzheimer's disease with cerebrovascular disease
    Gallart-Palau, Xavier
    Lee, Benjamin S. T.
    Adav, Sunil S.
    Qian, Jingru
    Serra, Aida
    Park, Jung Eun
    Lai, Mitchell K. P.
    Chen, Christopher P.
    Kalaria, Raj N.
    Sze, Siu Kwan
    MOLECULAR BRAIN, 2016, 9
  • [47] Mitochondrial dysfunction in lymphocytes - a potential biomarker for Alzheimer's disease
    Leuner, K.
    Pantel, J.
    Schulz, K.
    Schuett, T.
    Lipka, U.
    Eckert, A.
    Mueller, W. E.
    PHARMACOPSYCHIATRY, 2009, 42 (05) : 229 - 229
  • [48] Unlocking the enigma: unraveling multiple cognitive dysfunction linked to glymphatic impairment in early Alzheimer's disease
    Zhong, Jiayi
    Zhang, Xiaochen
    Xu, Huanyu
    Zheng, Xiaoran
    Wang, Luyao
    Jiang, Jiehui
    Li, Yunxia
    FRONTIERS IN NEUROSCIENCE, 2023, 17
  • [49] The Potential Cerebrovascular Sequelae of Coronavirus Disease 19 in Alzheimer's Disease: Coincidental or Causative?
    Egiz, Abdullah
    Farajzadeh-Asl, Sarvin
    Abouzeid, Bassel Alaa
    Al-Shaharli, Radhi
    Al-Assadi, Rand
    EURASIAN JOURNAL OF MEDICINE, 2022, 54 (01): : 85 - 86
  • [50] "Connecting the Dots" from Blood Brain Barrier Dysfunction to Neuroinflammation and Alzheimer's Disease
    Maiese, Kenneth
    CURRENT NEUROVASCULAR RESEARCH, 2014, 11 (03) : 187 - 189
12345